Specifications of the NGF recombinant human nerve growth factor
The NGF has proved to be a fundamental component in Neurotrophic Keratitis treatments. However, it's use, up to a little while ago, was not permitted because it was of animal nature and it could not be commercialised or used in random studies. Today, thanks to a clinical sperimentation carried out by the Dompè Group, the human recombinant offers new hopes.
The NGF has proved to be a fundamental component in Neurotrophic Keratitis treatments. However, it's use, up to a little while ago, was not permitted because it was of animal nature and it could not be commercialised or used in random studies. Today, thanks to a clinical sperimentation carried out by the Dompè Group, the human recombinant offers new hopes.
The first international clinical ophthalmological trial concerning treatment of neurotrophic keratitis
Dompè: focusing on the development of innovative solutions
it
Introduction - Eugenio Aringhieri MD - Dompè
Neurotrophic Keratitis: the rhNGF treatment
it
Prof. Stefano Bonini
Neurotrophic Keratitis
Prof. Stefano Bonini
Specifications of the NGF recombinant human nerve growth factor
Prof. Stefano Bonini
The contribution of industry - Eugenio Aringhieri C.E.O Dompè Group
it
Questions & answers - 1st part
it
Questions & answers - 2nd part
it
Questions & answers - 3rd part
it